Recent research investigates an injectable in situ gelling system aimed at providing sustained nicotine release. This approach could offer a new method for nicotine replacement therapy, potentially improving adherence and effectiveness in smoking cessation efforts.
Such systems are designed to deliver nicotine gradually over time, reducing withdrawal symptoms and cravings, and supporting smokers in quitting more effectively.